Clinical studies recruiting near Linz

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 Austrian PBC Registry
Phase N/A · Ordensklinikum Linz - Barmherzige Schwestern · Medical University of Vienna · NCT07598669 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Kepler Universitätsklinikum-Department for Oncology and Hema · Merck Sharp & Dohme LLC · NCT06393374 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Ordensklinikum Linz GmbH Elisabethinen · Pfizer · NCT06758401 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · Ordensklinikum Linz GmbH Elisabethinen · Miltenyi Biomedicine GmbH · NCT04844866 Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
Phase 3 · Kepler University Hospital · Vastra Gotaland Region · NCT06419946 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Krankenhaus der Barmherzigen Brueder Linz · Amgen · NCT07037433 - IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Misma
Phase 2 · Ordensklinikum Linz GmbH · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT06856837 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · Innere Medizin · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615 A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Phase 3 · Allgemeines Krankenhaus der Stadt Linz · argenx · NCT06544499 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Ordensklinikum Linz GmbH Elisabethinen · Eli Lilly and Company · NCT06890598 A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in
Phase N/A · Ordensklinikum Linz Elisabethinen · Hoffmann-La Roche · NCT07284121 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Kepler University Hospital · Regeneron Pharmaceuticals · NCT06091865 NEUROwave - Extracorporeal Shock Wave Therapy (ESWT) in Acute Traumatic Complete (AIS A) and Incomplete (AIS B-D) Cross-
NA · Unfallkrankenhaus Linz · AUVA · NCT04474106 GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of
Phase N/A · Ordensklinikum Linz Elisabethinen · Goethe University · NCT02872987 A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes
Phase N/A · Kepler Universitätsklinikum Linz · Bristol-Myers Squibb · NCT05489705 Duroplasty for Injured Cervical Spinal Cord With Uncontrolled Swelling
NA · Kepler University Hospital · St George's, University of London · NCT04936620 A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Phase 3 · Johannes Kepler Universitat Linz, Universitatsklinik fur Inn · Takeda · NCT06963827 A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · Ordensklinikum Linz GmbH Elisabethinen · Janssen Research & Development, LLC · NCT06319820 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Ordensklinikum Linz Elisabethinen /ID# 240967 · AbbVie · NCT04928846 ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administer
Phase 1/Phase 2 · Kepler University Hospital · Ionis Pharmaceuticals, Inc. · NCT06430385 Pan Tumor Rollover Study
Phase 2 · Ordensklinikum Linz GmbH Elisabethinen · Bristol-Myers Squibb · NCT03899155 Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC Wi
Phase 3 · Research Site · AstraZeneca · NCT06357533 High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Phase 3 · Kepler Universitatsklinikum Linz · Gustave Roussy, Cancer Campus, Grand Paris · NCT04221035 Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk Oligosaccharides (HMOs)
NA · Kepler Universitätsklinikum Linz · Société des Produits Nestlé (SPN) · NCT06212427 A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancre
Phase 3 · Investigative Site AT004 · Incyte Corporation · NCT07522073 DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carbop
Phase 3 · Hospital Elisabethinen Linz · Boehringer Ingelheim · NCT07472517 Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Phase 4 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05803941 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06830720

Look up another city

Look up another condition